Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Opeyemi Oluwayemisi Ayodele, Funmilayo Dorcas Onajobi & Omolaja Osoniyi. (2019) In vitro anticoagulant effect of Crassocephalum crepidioides leaf methanol extract and fractions on human blood. Journal of Experimental Pharmacology 11, pages 99-107.
Read now
Read now
FK Mampuya, WJ Steinberg & JE Raubenheimer. (2018) Risk factors and HIV infection among patients diagnosed with deep vein thrombosis at a regional/tertiary hospital in Kimberley, South Africa. South African Family Practice 60:4, pages 107-113.
Read now
Read now
Andrew Blann. (2015) Nonvitamin K antagonist oral anticoagulants (NOACs): the tide continues to come in. Vascular Health and Risk Management 11, pages 489-492.
Read now
Read now
J Lasierra-Cirujeda, P Coronel, MJ Aza & M Gimeno. (2010) Use of sulodexide in patients with peripheral vascular disease. Journal of Blood Medicine 1, pages 105-114.
Read now
Read now
Olusegun Osinbowale, Lobna Ali & Yung-Wei Chi. (2010) Venous Thromboembolism: A Clinical Review. Postgraduate Medicine 122:2, pages 54-65.
Read now
Read now
Articles from other publishers (10)
Katelyn Arnold, Yi-En Liao & Jian Liu. (2020) Potential Use of Anti-Inflammatory Synthetic Heparan Sulfate to Attenuate Liver Damage. Biomedicines 8:11, pages 503.
Crossref
Crossref
Joseph D. Raffetto, Fiorella Calanni, Paolo Mattana & Raouf A. Khalil. (2019) Sulodexide promotes arterial relaxation via endothelium-dependent nitric oxide-mediated pathway. Biochemical Pharmacology 166, pages 347-356.
Crossref
Crossref
Davide Imberti, Cecilia Becattini, Enrico Bernardi, Giuseppe Camporese, Claudio Cuccia, Francesco Dentali & Damiano Paretti. (2018) Multidisciplinary approach to the management of patients with pulmonary embolism and deep vein thrombosis: a consensus on diagnosis, traditional therapy and therapy with rivaroxaban. Internal and Emergency Medicine 13:7, pages 1037-1049.
Crossref
Crossref
Andrew D Blann & Gregory Y H Lip. (2016) Non-vitamin K antagonist oral anticoagulants (NOACs) for the management of venous thromboembolism. Heart 102:12, pages 975-983.
Crossref
Crossref
Rolien Bosch, Marie-José van Lierop, Pieter-Jan de Kam, Annelieke C. Kruithof, Jacobus Burggraaf, Rik de Greef, Sandra A.G. Visser, Amy O. Johnson-Levonas & Huub-Jan Kleijn. (2016) A PK-PD model-based assessment of sugammadex effects on coagulation parameters. European Journal of Pharmaceutical Sciences 84, pages 9-17.
Crossref
Crossref
Andrew Blann. (2014) Prevention and treatment of venous thromboembolism: the nurse's role in management. British Journal of Cardiac Nursing 9:11, pages 534-540.
Crossref
Crossref
Cesar Roberto Busato, Ricardo Zanetti Gomes, Dieyson Martins de Melo Costa & Tiago Francisco Meleiro Zubiolo. (2014) Evaluation of thromboprophylaxis in medium-sized general hospital. Jornal Vascular Brasileiro 13:1, pages 05-11.
Crossref
Crossref
R S FigueiredoG Stansby & V Bhattacharya. (2012) Primary prevention of venous thromboembolism. Phlebology: The Journal of Venous Disease 27:2_suppl, pages 23-32.
Crossref
Crossref
Gabriella Gray & Catherine Nelson-Piercy. (2012) Thromboembolic disorders in obstetrics. Best Practice & Research Clinical Obstetrics & Gynaecology 26:1, pages 53-64.
Crossref
Crossref
Salvador Rico, Rosa Maria Antonijoan, Ignasi Gich, Montserrat Borrell, Jordi Fontcuberta, Mayte Monreal, Javier Martinez-Gonzalez & Manel J. Barbanoj. (2011) Safety Assessment and Pharmacodynamics of a Novel Ultra Low Molecular Weight Heparin (RO-14) in Healthy Volunteers – A First-Time-In-Human Single Ascending Dose Study. Thrombosis Research 127:4, pages 292-298.
Crossref
Crossref